13 — HUTCHMED (China) Share News
0.000.00%
Last trade - 00:00- HK$22.41bn
- HK$12.56bn
- $630.20m
- 23
- 38
- 60
- 32
REG - Hutchmed China Ltd - HUTCHMED to Announce 2024 HY Financial Results
AnnouncementRCS - Hutchmed China Ltd - Save the Date: HUTCHMED to Present R&D Updates
AnnouncementREG - Hutchmed China Ltd - European Commission Approval for FRUZAQLA
AnnouncementRCS - Hutchmed China Ltd - Lancet Publish Phase III ESLIM-01 Results
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Phase I Trial of HMPL-506
AnnouncementRCS - Hutchmed China Ltd - Nature Medicine Publish Phase III FRUTIGA Results
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Presentations at 2024 ASCO Annual Meeting
AnnouncementREG - Hutchmed China Ltd - Retirement of Chairman and new Chairman appointed
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Data to be Presented at EHA2024 Congress
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Phase II/III Trial with Hengrui
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Registrational Phase III Trial
AnnouncementREG - Hutchmed China Ltd - Result of AGM
AnnouncementREG - Hutchmed China Ltd - Directorate Change
AnnouncementREG - Hutchmed China Ltd - Positive CHMP Opinion for Fruquintinib
AnnouncementREG - Hutchmed China Ltd - Vesting of Awards Under the LTIP
AnnouncementREG - Hutchmed China Ltd - 2023 Annual Report and Notice of AGM
AnnouncementRCS - Hutchmed China Ltd - Data to be Presented at AACR Congress 2024
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED and Innovent Announce NDA Acceptance
Announcement